Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children
Clinical trial NCT04532229 · UNKNOWN
Trial details
- NCT number
- NCT04532229
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-03
- Primary completion
- 2023-10-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.